Evaluation of the use of Optiflow (Trade Mark) as a standard of care for oxygen delivery in critically ill patients in high acuity areas

To demonstrate what Optiflow (Trademark) as a standard of care for oxygen delivery has on clinical outcomes in high acuity patients in a combined unit (ICU/CCU/HDU)

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12614000458639

Enrollment

500

Registered

2014-05-02

Start date

2013-05-20

Completion date

2014-03-01

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The efficacy of introducing Optiflow as standard of care needs to be established in a robust way. It is proposed that a clinical reference centre will be established at the ICU/HDU/CCU at Tauranga Hospital (BOP DHB) where Optiflow will be introduced as the standard of care, therefore replacing all other oxygen delivery devices in use within the ICU, excluding NIV and INV devices. Tauranga Hospital is a secondary hospital that provides medical, surgical, paediatric, obstetric, gynaecology and mental health services to the population of the Western Bay of Plenty.

Interventions

To demonstrate that when Optiflow is introduced as the standard of care for oxygen delivery in a combined unit (ICU/CCU/HDU) superior outcomes shall be achieved. Optiflow delivers a wide range of oxygen percentages and flows. Optiflow is a medical device. Optiflow is a nasal cannula device and will be utilised for the duration of the patient's ICU/CCU/HDU stay

Study design

Allocation

Non-randomised trial

Intervention model

Other

Primary purpose

Treatment

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

All patients admitted to the ICU/HDU/CCU will be eligible for enrolment (convenience sampling) and there will be no withdrawals.

Exclusion criteria

Exclusion will only occur if there is a known contraindication to Optiflow (e.g. as per device specification)

Outcome results